LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 186 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $94,923 | +578.0% | 1,421 | +1444.6% | 0.01% | +600.0% |
Q4 2021 | $14,000 | +250.0% | 92 | +187.5% | 0.00% | – |
Q3 2021 | $4,000 | -94.6% | 32 | -95.9% | 0.00% | -100.0% |
Q3 2020 | $74,000 | +428.6% | 780 | +486.5% | 0.01% | +300.0% |
Q2 2020 | $14,000 | – | 133 | +1377.8% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 9 | -98.7% | 0.00% | -100.0% |
Q4 2019 | $73,000 | -49.3% | 705 | -51.3% | 0.01% | -50.0% |
Q3 2019 | $144,000 | +1100.0% | 1,447 | +1347.0% | 0.01% | +1300.0% |
Q1 2019 | $12,000 | -95.8% | 100 | -95.3% | 0.00% | -96.4% |
Q4 2018 | $289,000 | +556.8% | 2,137 | +410.0% | 0.03% | +460.0% |
Q1 2017 | $44,000 | -90.6% | 419 | -90.9% | 0.01% | -90.4% |
Q3 2016 | $467,000 | +2235.0% | 4,581 | +2190.5% | 0.05% | +1200.0% |
Q2 2015 | $20,000 | -60.0% | 200 | -78.9% | 0.00% | -75.0% |
Q4 2014 | $50,000 | -31.5% | 949 | -13.7% | 0.02% | -5.9% |
Q1 2014 | $73,000 | +1360.0% | 1,100 | +1000.0% | 0.02% | +750.0% |
Q4 2013 | $5,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |